Latest News

eUpdate – Treatment Recommendations
eUpdate – Treatment Recommendations
19 Sep 2016 Press Release: Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
19 Sep 2016 EMA Recommends Granting a Marketing Authorisation for Palbociclib Breast cancer - Anticancer agents & Biologic therapy
16 Sep 2016 Start-Up of Human Cancer Models Initiative Translational research
15 Sep 2016 Niraparib Receives FDA Fast Track Designation for the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
08 Sep 2016 CDK4/6 Inhibitor LEE011 (Ribociclib) Receives FDA Breakthrough Therapy Designation Breast cancer - Anticancer agents & Biologic therapy
07 Sep 2016 Potential Risk of Hepatitis B Reactivation After Treatment With BCR-ABL Tyrosine Kinase Inhibitors Anticancer agents & Biologic therapy
06 Sep 2016 Press Release: ESMO Rewards Outstanding Oncologists
06 Sep 2016 Annals of Oncology Press Release: Deaths from Ovarian Cancer Decline Worldwide Due to Oral Contraceptive Use Gynaecologic malignancies
05 Sep 2016 Completion of Rolling Submission of New Drug Application for Brigatinib to the US FDA Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
31 Aug 2016 A New Report on Cancer Sites Linked to Overweight and Obesity Epidemiology/Etiology/Cancer Prevention
29 Aug 2016 Latest NICE Medtech Innovation Briefings and Technology Appraisal Guidance Recommendations for Cancer Breast cancer - Genitourinary cancers - Haematologic malignancies - Lung and other thoracic tumours - Gastrointestinal cancers